Delivery Order SPE2DB20D9331-SPE2DB26FL0C5
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract, valued at $10,093.50, to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S to support the medical supply needs of the agency. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, which has a potential value...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count units. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units) with a ceiling value of $3,458.51. The contract was awarded on September 9, 2025, with an ultimate completion date of September 30, 2025, utilizing firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $3,458.51 for 30 capsules of NUPLAZID 34 mg. The award, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,364.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a period of performance through November 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order under a firm fixed-price contract with a ceiling value of $10,375.53. The order represents no set-aside designation and carries an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,458.51 firm fixed-price delivery order is for the provision of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period through April 8, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB26FL0C5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,751.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count packaging). This firm fixed-price delivery order, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, indicating the award was made through open competition. The delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to ensure reliable pharmaceutical supply chains supporting Department of Defense medical facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under PPV-G GEN V (contract SPE2DR) valued at up to $499,999,999 and extending through December 31, 2036, positioning the company as a regional prime vendor contractor. The broader PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables. As a critical supplier within the federal pharmaceutical supply chain since its SAM registration in 2001, DMS Pharmaceutical Group has demonstrated substantial contracting activity with the Defense Logistics Agency, with this delivery order representing one of numerous orders issued to fulfill recurring medical supply requirements for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 10/23/25 |